Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
My Portfolio
Sangamo Therapeutics
(NQ:
SGMO
)
15.75
USD
-0.44 (-2.72%)
Official Closing Price
Updated: 7:58 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Sangamo Therapeutics
< Previous
1
2
3
4
5
6
7
8
9
...
57
58
Next >
The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration
January 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
ABCL
IBB
AVIR
From
Benzinga
Sangamo Therapeutics Announces Departure of Chief Financial Officer Sung Lee
January 06, 2021
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that Chief Financial Officer Sung Lee is leaving the Company to pursue a new opportunity overseas. Mr. Lee’s last...
From
Business Wire News Releases
Benzinga's Top Upgrades, Downgrades For January 6, 2021
January 06, 2021
Upgrades For Regenxbio Inc (NASDAQ:RGNX), Raymond James upgraded the previous rating of Outperform to Strong Buy. For ...
Tags
SEIC
BRBR
NSTG
From
Benzinga
Sangamo Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 05, 2021
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present a corporate overview at the 39th Annual J.P. Morgan Healthcare Conference on...
From
Business Wire News Releases
The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica
December 29, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
EW
AMPH
PRAX
From
Benzinga
My “Trade Ideas Special” edition for the last week of 2020
December 26, 2020
Tags
MARA
OCG
IPOC
From
AC Investor Blog
The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut
December 23, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
FDA
BPMC
ATRC
From
Benzinga
88 Biggest Movers From Yesterday
December 23, 2020
Gainers Ocugen Inc (NASDAQ: OCGN) shares surged 173.9% to close at $0.8052 on Tuesday after the company and Bharat Biotech ...
Tags
PTAC
Communications Equipment
BRPA
From
Benzinga
Sangamo Therapeutics Scores Relative Strength Rating Upgrade
December 23, 2020
Sangamo Therapeutics sees its Relative Strength Rating hit the elite 90-plus level.
From
Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 22, 2020
Gainers Ocugen (NASDAQ:OCGN) stock moved upwards by 141.83% to $0.71 during Tuesday's regular session. As of 12:31 ...
Tags
Top Gainers
NH
Markets
From
Benzinga
61 Stocks Moving In Tuesday's Mid-Day Session
December 22, 2020
Gainers Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares jumped 202% to $74.37 after jumping over 60% on Monday. Ocugen ...
Tags
EYES
CYCC
AMTX
From
Benzinga
Stocks That Hit 52-Week Highs On Tuesday
December 22, 2020
During Tuesday's morning session, 342 companies made new 52-week highs. Intriguing Points: The largest company by ...
Tags
WRAP
SEEL
RDFN
From
Benzinga
The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes
December 22, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
VTGN
CMPI
CRTX
From
Benzinga
42 Stocks Moving in Tuesday's Pre-Market Session
December 22, 2020
Gainers Aurora Mobile Limited (NASDAQ: JG) shares rose 56.4% to $4.99 in pre-market trading after the company reported a ...
Tags
EYEG
Benzinga
Markets
From
Benzinga
Notable Monday Option Activity: SGMO, PENN, ZS
December 21, 2020
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Sangamo Therapeutics Inc (SGMO), where a total of 16,270 contracts have traded so far,...
Tags
Stocks
From
Market News Video
First Week of SGMO August 2021 Options Trading
December 18, 2020
Investors in Sangamo Therapeutics Inc (SGMO) saw new options become available this week, for the August 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to...
Tags
Stocks
From
Market News Video
If You Invested $5,000 in Pfizer In January, Here's How Much You'd Have Now
December 17, 2020
Shares didn't benefit much from the pharma's efforts to help to save humanity.
Tags
VTRS
SGMO
Market News
From
Motley Fool
Stocks To Watch: Sangamo Therapeutics Sees RS Rating Rise To 85
December 15, 2020
Sangamo Therapeutics sees its Relative Strength Rating hit the 80-plus level.
From
Investor's Business Daily
72 Biggest Movers From Friday
December 14, 2020
Gainers AbCellera Biologics Inc. (NASDAQ: ABCL) shares jumped 194.5% to close at $58.90 after the company priced its IPO at $20 ...
Tags
SNOA
APOP
AESE
From
Benzinga
Should Investors Be Watching These Biotech Stocks Going Into 2021? 2 Up 300%+ Since March
December 11, 2020
From
Stockmarket.com
60 Stocks Moving In Friday's Mid-Day Session
December 11, 2020
Gainers TPG Pace Beneficial Finance Corp. (NYSE: TPGY) shares jumped 111.5% to $23.48 on a merger deal with EV charging company ...
Tags
ALXO
News
TCDA
From
Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street
December 11, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
IPHA
SIBN
XERS
From
Benzinga
84 Biggest Movers From Yesterday
December 11, 2020
Gainers SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) shares climbed 176.4% to close at $17.66 on Thursday after climbing 73% on ...
Tags
AQB
TTGT
PRLD
From
Benzinga
Noteworthy Thursday Option Activity: TWNK, OKTA, SGMO
December 10, 2020
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Hostess Brands Inc (TWNK), where a total of 9,996 contracts have traded so far, representing...
Tags
Stocks
From
Market News Video
Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels in 3x1013 VG/KG Cohort Through One Year Following Hemophilia A Gene Therapy
December 07, 2020
Pfizer Inc. (NYSE: PFE) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced updated follow-up data from the Phase 1/2 Alta study of giroctocogene fitelparvovec...
From
Business Wire News Releases
Cramer Advises Viewers On Ballard Power Systems, Blink Charging And More
November 24, 2020
On CNBC's "Mad Money Lightning Round," Jim Cramer said he would wait to buy Ballard Power Systems Inc (NASDAQ: BLDP). The ...
Tags
Market News
PCG
CNBC
From
Benzinga
This Company's New Approach Could Slash Gilead's Profit From HIV Drugs
November 22, 2020
The company's HIV franchise faces threats from many different directions.
Tags
GILD
TEVA
Market News
From
Motley Fool
Look Under The Hood: PBE Has 22% Upside
November 17, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Sangamo Therapeutics Sees IBD RS Rating Improve To 73
November 13, 2020
Sangamo Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
From
Investor's Business Daily
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
November 05, 2020
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the following investor conferences:
From
Business Wire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
57
58
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.